Lower vitamin D levels and VDR variants are risk factors for breast cancer: an updated meta-analysis

Nucleosides Nucleotides Nucleic Acids. 2023;42(1):17-37. doi: 10.1080/15257770.2022.2107217. Epub 2022 Aug 9.

Abstract

Inadequate vitamin D levels and vitamin D variants have been shown to be associated with breast cancer (BC), however the results are inconsistent. To reach a definitive conclusion the present meta-analysis was conducted. When compared to healthy controls, BC patients had reduced vitamin D levels (standard difference in means = -0.564, p = 0.003). The meta-analysis revealed that the FokI mutation was linked with an increased BC susceptibility (CC vs. TT: OR = 1.107, p = 0.001, CC vs. TC + TT: OR = 1.114, p = 0.020). There was no role of other VDR variants (BsmI, TaqI, and ApaI). FokI mutation and diminished vitamin D increase the likelihood of developing BC.

Keywords: Breast cancer; VDR; meta-analysis; polymorphism; susceptibility; vitamin D3.

Publication types

  • Meta-Analysis

MeSH terms

  • Breast Neoplasms*
  • Female
  • Genetic Predisposition to Disease*
  • Humans
  • Receptors, Calcitriol / genetics
  • Risk Factors
  • Vitamin D

Substances

  • Receptors, Calcitriol
  • Vitamin D
  • VDR protein, human